SYK and lymphoma: Various small molecules engaging BCR or its downstream signaling, such as BTK [12,23,25,26], CDK [25], PI3K [23,27], BCL-2 [28] or SYK inhibitors [26], have shown synergistic activity with BET inhibition in lymphomas.